CLINICAL DEVELOPMENT OF A NOVEL CD5 KNOCKED OUT ANTI-CD5 CAR T CELL PRODUCT FOR T CELL LYMPHOMA

被引：0
|
作者：
Patel, R. [1 ]
Ghilardi, G. [1 ]
Porazzi, P. [1 ]
Yang, S. [2 ]
Qian, D. [2 ]
Zhang, Y. [1 ]
Pajarillo, R. [1 ]
Schuster, S. [3 ]
Barta, S. [3 ]
Nimmagadda, A. [2 ]
Snook, A. [2 ]
Siciliano, N. [2 ]
Ruella, M. [1 ]
机构：
[1] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA USA
[2] ViTToria Biotherapeut, Philadelphia, PA USA
[3] Univ Penn, Dept Med, Philadelphia, PA USA
来源：
CYTOTHERAPY | 2023年 / 25卷 / 06期
关键词：
Chimeric antigen receptor; T cell lymphoma; CRISPR Cas9;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
1072
引用
收藏
页码：S248 / S248
页数：1
相关论文
共 50 条
  • [31] Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor
    Chen, K. H.
    Wada, M.
    Pinz, K. G.
    Liu, H.
    Lin, K-W
    Jares, A.
    Firor, A. E.
    Shuai, X.
    Salman, H.
    Golightly, M.
    Lan, F.
    Senzel, L.
    Leung, E. L.
    Jiang, X.
    Ma, Y.
    LEUKEMIA, 2017, 31 (10) : 2151 - 2160
  • [32] Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor
    K H Chen
    M Wada
    K G Pinz
    H Liu
    K-W Lin
    A Jares
    A E Firor
    X Shuai
    H Salman
    M Golightly
    F Lan
    L Senzel
    E L Leung
    X Jiang
    Y Ma
    Leukemia, 2017, 31 : 2151 - 2160
  • [33] CD5(-) CD56(+) T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas
    Emile, JF
    Boulland, ML
    Haioun, C
    Kanavaros, P
    Petrella, T
    DelfauLarue, MH
    Bensussan, A
    Farcet, JP
    Gaulard, P
    BLOOD, 1996, 87 (04) : 1466 - 1473
  • [34] Anti-CD5 CAR-T cells with a tEGFR safety switch exhibit potent toxicity control
    Lin, Haolong
    Cheng, Jiali
    Zhu, Li
    Zeng, Yuhao
    Dai, Zhenyu
    Zhang, Yicheng
    Zhu, Xiaojian
    Mu, Wei
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [35] Anti-CD5-CAR-T-cell-Therapy-iCell-Gene-TherapeuticsVarious toxicities
    Reactions Weekly, 2024, 2015 (1) : 41 - 41
  • [36] T Cell Calcium Signaling Regulation by the Co-Receptor CD5
    Freitas, Claudia M. Tellez
    Johnson, Deborah K.
    Weber, K. Scott
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
  • [37] CD5 modulates regulatory T cell function, proliferation, and survival.
    McGuire, Donald
    Sestero, Christine
    De Sarno, Patrizia
    Raman, Chander
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [38] Determination of the tyrosine phosphorylation sites in the T cell transmembrane glycoprotein CD5
    Dennehy, KM
    Ferris, WF
    Veenstra, H
    Zuckerman, LA
    Killeen, N
    Beyers, AD
    INTERNATIONAL IMMUNOLOGY, 2001, 13 (02) : 149 - 156
  • [39] CD5 deletion enhances the antitumor activity of adoptive T cell therapies
    Patel, Ruchi P.
    Ghilardi, Guido
    Zhang, Yunlin
    Chiang, Yi-Hao
    Xie, Wei
    Guruprasad, Puneeth
    Kim, Ki Hyun
    Chun, Inkook
    Angelos, Mathew G.
    Pajarillo, Raymone
    Hong, Seok Jae
    Lee, Yong Gu
    Shestova, Olga
    Shaw, Carolyn
    Cohen, Ivan
    Gupta, Aasha
    Vu, Trang
    Qian, Dean
    Yang, Steven
    Nimmagadda, Aditya
    Snook, Adam E.
    Siciliano, Nicholas
    Rotolo, Antonia
    Inamdar, Arati
    Harris, Jaryse
    Ugwuanyi, Ositadimma
    Wang, Michael
    Carturan, Alberto
    Paruzzo, Luca
    Chen, Linhui
    Ballard, Hatcher J.
    Blanchard, Tatiana
    Xu, Chong
    Abdel-Mohsen, Mohamed
    Gabunia, Khatuna
    Wysocka, Maria
    Linette, Gerald P.
    Carreno, Beatriz
    Barrett, David M.
    Teachey, David T.
    Posey, Avery D.
    Powell, Daniel J.
    Sauter, C. Tor
    Pileri, Stefano
    Pillai, Vinodh
    Scholler, John
    Rook, Alain H.
    Schuster, Stephen J.
    Barta, Stefan K.
    Porazzi, Patrizia
    SCIENCE IMMUNOLOGY, 2024, 9 (97)
  • [40] A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5
    Bikah, G
    Lynd, FM
    Aruffo, AA
    Ledbetter, JA
    Bondada, S
    INTERNATIONAL IMMUNOLOGY, 1998, 10 (08) : 1185 - 1196
12345